FDA Adverse Event Malfunction Summary report: N

CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM

MDR report key: 19113233 · Received April 15, 2024

Report

Report Number
2029046-2024-01248
Event Type
Malfunction
Date Received
April 15, 2024
Date of Event
March 21, 2024
Report Date
April 15, 2024
Manufacturer
BIOSENSE WEBSTER INC
Product Code
DYB
UDI-DI
10846835016277
PMA / PMN Number
K170997
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

IT WAS REPORTED THAT A PATIENT UNDERWENT AN ATRIAL FIBRILLATION (AFIB) ABLATION PROCEDURE WITH A CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM AND THERE WAS A NYLON MATERIAL UNRAVELING FROM THE INSIDE OF THE SHEATH. IT WAS REPORTED THAT WHEN REMOVING THE CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM FROM THE GROIN, POST PROCEDURE, THERE WAS WHAT LOOKED LIKE A NYLON MATERIAL UNRAVELING FROM THE INSIDE OF THE SHEATH. THERE WAS NO RESISTANCE. NO PATIENT CONSEQUENCES NOTES. DEVICE EVALUATION DETAILS: THE DEVICE WAS RETURNED TO BIOSENSE WEBSTER INC (BWI) FOR EVALUATION AND THE EVALUATION HAS BEEN COMPLETED. A VISUAL INSPECTION, MICROSCOPIC EXAMINATION, AND FOURIER TRANSFORMED INFRARED SPECTROSCOPY (FT-IR) EVALUATION OF THE RETURNED DEVICE WAS PERFORMED FOLLOWING BWI PROCEDURES. THE CUSTOMER REPORTED THAT A NYLON MATERIAL UNRAVELING WAS OBSERVED WHEN REMOVING THE CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM FROM THE GROIN; HOWEVER, DURING THE ANALYSIS IN THE LAB A VISUAL INSPECTION REVEALED ANY ANOMALIES OR PHYSICAL DAMAGE ON THE DEVICE. AFTERWARD, THE SHAFT WAS INSPECTED FROM THE INSIDE AND DELAMINATION WAS OBSERVED. DUE TO THIS CONDITION AN FT-IR TEST WAS PERFORMED AND RESULTS REVEALED THAT THE INFRARED SPECTRUM OBTAINED FROM FOREIGN MATERIAL EXHIBITED THE CHARACTERISTIC INFRARED SPECTRUM FOR POLYTETRAFLUOROETHYLENE (PT-FE). A DEVICE HISTORY RECORD WAS PERFORMED FOR THE FINISHED DEVICE BATCH NUMBER, AND NO INTERNAL ACTIONS WERE IDENTIFIED. THE FAILURE OBSERVED WITH THE PT-FE COULD BE RELATED TO THE ISSUES REPORTED BY THE CUSTOMER; THEREFORE, THE CUSTOMER COMPLAINT WAS CONFIRMED. THE POTENTIAL CAUSE OF THE PTFE ISSUE COULD BE RELATED TO THE EXCESSIVE FORCE OR MANIPULATION OF THE DEVICE DURING THE PROCEDURE; HOWEVER, THIS CANNOT BE CONCLUSIVELY DETERMINED. THE INSTRUCTIONS FOR USE CONTAIN THE FOLLOWING RECOMMENDATIONS: PRIOR TO INSERTING THE DEVICE INTO THE PATIENT, PRE-ASSEMBLE SHEATH, DILATOR AND STYLET ON THE TABLE. ADVANCE THE NEEDLE THROUGH THE DILATOR AND CHECK FOR EXCESSIVE RESISTANCE AS THE TIP OF THE NEEDLE ADVANCES THROUGH THE CURVATURE OF THE SHEATH/DILATOR ASSEMBLY. AS PART OF BIOSENSE WEBSTER¿S QUALITY PROCESS, ALL DEVICES ARE MANUFACTURED, INSPECTED, AND RELEASED TO APPROVED SPECIFICATIONS. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REF. (B)(4).

Additional Manufacturer Narrative · 0

ON 29-APR-2024, THE BWI PRODUCT ANALYSIS LAB RECEIVED THE COMPLAINT DEVICE FOR EVALUATION. THE PRODUCT ANALYSIS HAS BEGUN BUT IS NOT COMPLETED AT THIS TIME. WHEN THE INVESTIGATIONAL ANALYSIS HAS BEEN COMPLETED, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REF. # (B)(4).

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY BIOSENSE WEBSTER INC., OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, BIOSENSE WEBSTER INC., OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REF#: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT UNDERWENT AN ATRIAL FIBRILLATION (AFIB) ABLATION PROCEDURE WITH A CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM AND THERE WAS A NYLON MATERIAL UNRAVELING FROM THE INSIDE OF THE SHEATH. IT WAS REPORTED THAT WHEN REMOVING THE CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM FROM THE GROIN, POST PROCEDURE, THERE WAS WHAT LOOKED LIKE A NYLON MATERIAL UNRAVELING FROM THE INSIDE OF THE SHEATH. THERE WAS NO RESISTANCE. NO PATIENT CONSEQUENCES NOTES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1406696 CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM INTRODUCER, CATHETER DYB BIOSENSE WEBSTER INC 00002527 10846835016277

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown